Product
Pfizer-BioNTech COVID-19 Vaccine
Aliases
COVID VACCINE, Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine
5 clinical trials
7 indications
Indication
COVID-19Indication
Kidney TransplantIndication
Liver Transplant RecipientsIndication
Allergic ReactionIndication
Mast Cell DisorderIndication
Systemic Allergic ReactionIndication
Chronic Kidney DiseaseClinical trial
Vaccine Effectiveness Study of Pfizer-BNT Vaccines - Kaiser Permanente Southern CaliforniaStatus: Recruiting, Estimated PCD: 2025-06-15
Clinical trial
A Randomized Study to Evaluate Antibody Response to an Additional Dose of SARS-CoV-2 Vaccination With and Without Immunosuppression Reduction in Kidney and Liver Transplant RecipientsStatus: Active (not recruiting), Estimated PCD: 2024-02-28
Clinical trial
Systemic Allergic Reactions to SARS-CoV-2 VaccinationStatus: Completed, Estimated PCD: 2022-04-20
Clinical trial
A Randomized, Placebo-controlled Crossover Study to Assess the Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial DoseStatus: Completed, Estimated PCD: 2022-06-17
Clinical trial
A Multi-Centre 12 Month Parallel-Group Randomized Control Trial of BNT162b2 Versus mRNA( Messenger Ribonucleic Acid) -1273 COVID-19 Vaccine Boosters in Chronic Kidney Disease and Dialysis Patients With Poor Humoral Response Following COVID-19 ( Corona Virus Disease of 2019)VaccinationStatus: Terminated, Estimated PCD: 2022-05-11